![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CARM1 |
Gene summary for CARM1 |
![]() |
Gene information | Species | Human | Gene symbol | CARM1 | Gene ID | 10498 |
Gene name | coactivator associated arginine methyltransferase 1 | |
Gene Alias | PRMT4 | |
Cytomap | 19p13.2 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | Q86X55 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
10498 | CARM1 | LZE4T | Human | Esophagus | ESCC | 1.63e-02 | 6.60e-02 | 0.0811 |
10498 | CARM1 | LZE7T | Human | Esophagus | ESCC | 4.62e-09 | 3.55e-01 | 0.0667 |
10498 | CARM1 | LZE20T | Human | Esophagus | ESCC | 7.59e-05 | 1.11e-01 | 0.0662 |
10498 | CARM1 | LZE22T | Human | Esophagus | ESCC | 3.69e-02 | 1.47e-01 | 0.068 |
10498 | CARM1 | LZE24T | Human | Esophagus | ESCC | 6.71e-10 | 2.41e-01 | 0.0596 |
10498 | CARM1 | LZE21T | Human | Esophagus | ESCC | 2.86e-05 | 3.74e-01 | 0.0655 |
10498 | CARM1 | P1T-E | Human | Esophagus | ESCC | 1.17e-03 | 3.23e-01 | 0.0875 |
10498 | CARM1 | P2T-E | Human | Esophagus | ESCC | 3.63e-11 | 1.02e-01 | 0.1177 |
10498 | CARM1 | P4T-E | Human | Esophagus | ESCC | 4.22e-17 | 3.28e-01 | 0.1323 |
10498 | CARM1 | P5T-E | Human | Esophagus | ESCC | 1.67e-18 | 2.18e-01 | 0.1327 |
10498 | CARM1 | P8T-E | Human | Esophagus | ESCC | 5.31e-19 | 2.99e-01 | 0.0889 |
10498 | CARM1 | P9T-E | Human | Esophagus | ESCC | 1.06e-18 | 3.37e-01 | 0.1131 |
10498 | CARM1 | P10T-E | Human | Esophagus | ESCC | 1.29e-22 | 3.95e-01 | 0.116 |
10498 | CARM1 | P12T-E | Human | Esophagus | ESCC | 1.59e-17 | 3.76e-01 | 0.1122 |
10498 | CARM1 | P15T-E | Human | Esophagus | ESCC | 1.57e-08 | 1.66e-01 | 0.1149 |
10498 | CARM1 | P16T-E | Human | Esophagus | ESCC | 1.24e-10 | 6.52e-02 | 0.1153 |
10498 | CARM1 | P17T-E | Human | Esophagus | ESCC | 5.39e-06 | 1.78e-01 | 0.1278 |
10498 | CARM1 | P20T-E | Human | Esophagus | ESCC | 6.89e-06 | 7.70e-02 | 0.1124 |
10498 | CARM1 | P21T-E | Human | Esophagus | ESCC | 4.19e-16 | 2.21e-01 | 0.1617 |
10498 | CARM1 | P22T-E | Human | Esophagus | ESCC | 1.43e-18 | 2.12e-01 | 0.1236 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:004560023 | Thyroid | ATC | positive regulation of fat cell differentiation | 32/6293 | 66/18723 | 8.63e-03 | 3.28e-02 | 32 |
GO:003314611 | Thyroid | ATC | regulation of intracellular estrogen receptor signaling pathway | 19/6293 | 35/18723 | 9.36e-03 | 3.44e-02 | 19 |
GO:005077312 | Thyroid | ATC | regulation of dendrite development | 46/6293 | 103/18723 | 1.26e-02 | 4.42e-02 | 46 |
GO:005159127 | Thyroid | ATC | response to cAMP | 42/6293 | 93/18723 | 1.34e-02 | 4.67e-02 | 42 |
Page: 1 2 3 4 5 6 7 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa015227 | Esophagus | ESCC | Endocrine resistance | 63/4205 | 98/8465 | 2.38e-03 | 6.58e-03 | 3.37e-03 | 63 |
hsa0152215 | Esophagus | ESCC | Endocrine resistance | 63/4205 | 98/8465 | 2.38e-03 | 6.58e-03 | 3.37e-03 | 63 |
hsa01522 | Liver | HCC | Endocrine resistance | 58/4020 | 98/8465 | 1.28e-02 | 3.19e-02 | 1.78e-02 | 58 |
hsa015221 | Liver | HCC | Endocrine resistance | 58/4020 | 98/8465 | 1.28e-02 | 3.19e-02 | 1.78e-02 | 58 |
hsa015226 | Oral cavity | OSCC | Endocrine resistance | 63/3704 | 98/8465 | 3.09e-05 | 1.31e-04 | 6.67e-05 | 63 |
hsa0152214 | Oral cavity | OSCC | Endocrine resistance | 63/3704 | 98/8465 | 3.09e-05 | 1.31e-04 | 6.67e-05 | 63 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CARM1 | SNV | Missense_Mutation | novel | c.687C>A | p.Asn229Lys | p.N229K | Q86X55 | protein_coding | deleterious(0) | probably_damaging(0.988) | TCGA-A8-A08S-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | anastrozole | SD |
CARM1 | SNV | Missense_Mutation | c.608N>T | p.Ala203Val | p.A203V | Q86X55 | protein_coding | tolerated(0.74) | benign(0.111) | TCGA-AN-A0AK-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
CARM1 | SNV | Missense_Mutation | c.1560N>C | p.Leu520Phe | p.L520F | Q86X55 | protein_coding | deleterious_low_confidence(0.05) | probably_damaging(0.991) | TCGA-D8-A27G-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
CARM1 | SNV | Missense_Mutation | c.950N>T | p.Ser317Phe | p.S317F | Q86X55 | protein_coding | deleterious(0.02) | probably_damaging(0.969) | TCGA-E9-A1RG-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Hormone Therapy | tamoxiphen | SD | |
CARM1 | insertion | Nonsense_Mutation | novel | c.377_378insACAGGCATAAGCCACCGTGCCCGGCTTATTATTTCTTGTAGAGA | p.Cys127GlnfsTer3 | p.C127Qfs*3 | Q86X55 | protein_coding | TCGA-A2-A0EQ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD | ||
CARM1 | SNV | Missense_Mutation | novel | c.1255N>T | p.Arg419Trp | p.R419W | Q86X55 | protein_coding | deleterious(0.01) | possibly_damaging(0.771) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
CARM1 | SNV | Missense_Mutation | c.330N>C | p.Gln110His | p.Q110H | Q86X55 | protein_coding | tolerated(0.09) | benign(0.106) | TCGA-JW-A5VI-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | topotecan | PD | |
CARM1 | SNV | Missense_Mutation | rs765573504 | c.1204N>A | p.Val402Met | p.V402M | Q86X55 | protein_coding | deleterious(0.01) | probably_damaging(0.957) | TCGA-A6-2672-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
CARM1 | SNV | Missense_Mutation | c.1430C>T | p.Thr477Met | p.T477M | Q86X55 | protein_coding | deleterious(0.01) | possibly_damaging(0.814) | TCGA-AA-3864-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
CARM1 | SNV | Missense_Mutation | c.1134N>T | p.Met378Ile | p.M378I | Q86X55 | protein_coding | tolerated(0.35) | benign(0.035) | TCGA-DM-A1HB-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
10498 | CARM1 | ENZYME, METHYL TRANSFERASE, DRUGGABLE GENOME | inhibitor | 336446915 | ||
10498 | CARM1 | ENZYME, METHYL TRANSFERASE, DRUGGABLE GENOME | EOSIN | EOSIN | 18348515 | |
10498 | CARM1 | ENZYME, METHYL TRANSFERASE, DRUGGABLE GENOME | inhibitor | 178103610 | ||
10498 | CARM1 | ENZYME, METHYL TRANSFERASE, DRUGGABLE GENOME | inhibitor | 310264736 | ||
10498 | CARM1 | ENZYME, METHYL TRANSFERASE, DRUGGABLE GENOME | inhibitor | 315661334 | ||
10498 | CARM1 | ENZYME, METHYL TRANSFERASE, DRUGGABLE GENOME | inhibitor | 178103609 | ||
10498 | CARM1 | ENZYME, METHYL TRANSFERASE, DRUGGABLE GENOME | inhibitor | 315661333 | BIIB021 |
Page: 1 |